A Prospective Open-Label Multicentre Trial on the Use of 1 G, Once Daily Ceftriaxone in Lower Respiratory Tract Infections
This prospective. single open-label sludy was conducted in 14 Canadian centres to assess lhe efncacy of I g, once a day intravenous ceftriaxone treatment administered for a minimum of three days in patients with lower respiratory tract infection. There were 137 patients enrolled. Age varied between...
Saved in:
Main Authors: | Donald E Low, Lionel A Mandell |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1994-01-01
|
Series: | Canadian Journal of Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/1994/421905 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Once-Daily Dosing of Aminoglycosides
by: William A Craig
Published: (1994-01-01) -
Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: an uncontrolled, open-label, multicentre study
by: Shan Chen, et al.
Published: (2013-12-01) -
Grepafloxacin Clinical Program for Lower Respiratory Tract Infections
by: Arne C Rodloff
Published: (1998-01-01) -
The dawn of preventing respiratory syncytial virus lower respiratory tract infections in children
by: Z Dangor, et al.
Published: (2024-11-01) -
Current Antibiotic Treatment and Outcome for Lower Respiratory Tract Infections
by: Alasdair P MacGowan, et al.
Published: (1998-01-01)